Insider Selling: bluebird bio COO Sells 6,000 Shares of Stock (BLUE)
bluebird bio (NASDAQ:BLUE) COO Jeffrey Walsh unloaded 6,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $21.98, for a total value of $131,880.00. The transaction was disclosed in a document filed with the SEC, which is available at this link.
bluebird bio (NASDAQ:BLUE) traded down 1.09% on Friday, hitting $21.79. The stock had a trading volume of 338,995 shares. bluebird bio has a 52 week low of $17.03 and a 52 week high of $36.25. The stock has a 50-day moving average of $20.73 and a 200-day moving average of $24.95. The company’s market cap is $514.9 million.
bluebird bio (NASDAQ:BLUE) last released its earnings data on Tuesday, November 12th. The company reported ($0.26) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.25) by $0.01. The company had revenue of $6.39 million for the quarter, compared to the consensus estimate of $5.59 million. bluebird bio’s revenue was up 7417.6% compared to the same quarter last year. On average, analysts predict that bluebird bio will post $-1.52 earnings per share for the current fiscal year.
bluebird bio, Inc is a clinical-stage biotechnology company, the Company is focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.